SCHEDULE 13G
Statement of Beneficial Ownership
Silence Therapeutics plc Filed Acc 0000919574-26-006888
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Tetragon Financial Group Limited | 9,708,153 | 5.2% |
| Tetragon Financial Management LP | 9,708,153 | 5.2% |
| Patrick G. G. Dear | 9,708,153 | 5.2% |
| Reade E. Griffith | 9,708,153 | 5.2% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-12 SCHEDULE 13G/A · Raymond Debbane 4.6%
- 2026-11-05 SCHEDULE 13G · FMR LLC 7.1%
- 2026-10-13 SCHEDULE 13G/A · Tetragon Financial Group Limited 5.3%
- 2026-10-13 SCHEDULE 13G · Tetragon Financial Group Limited 5.2%
- 2026-08-13 SCHEDULE 13G/A · Raymond Debbane 7.0%
- 2026-08-13 SCHEDULE 13D/A · Richard Griffiths 7.97%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…